We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Julio Martinez-Clark, CEO at Bioaccess, a CRO that specializes in executing first-in-human trials outside the US. Bioaccess empowers Medtech and Biopharma innovators to accelerate early feasibility studies and first-in-human trials via Latin America, Eastern Europe, and Australia’s 40% faster approvals, 50% quicker enrollment, and 30% lower costs.
For sponsors, Bioccess is selling time – faster to first-in-human medical device trials and faster to pivotal trials and FDA approval.
For countries like Colombia and El Salvador, Bioaccess creates jobs, promoting economic growth, improving healthcare, increasing research and development, and gaining international recognition.
And for patients in LATAM, Bioaccess is providing accessibility to innovative medical devices.
Check out the main topics of discussion for this episode of the Life Sciences Today podcast:
- Who are your customers?
- How do you create value for your customers?
- How do you capture value from them?
- What are 3 things you want to achieve for your customers in the next 12-18 months?
Now, without further ado, we’re excited to share with you the next episode of the Life Sciences Today podcast.
Be sure to subscribe to the Life Sciences Today on your favorite podcasting platform:
Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.
If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.
Thanks so much for listening!
No comments:
Post a Comment